WallStreetZenWallStreetZen

NASDAQ: NBTX
Nanobiotix Sa Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsDividendOwnership

Be the first to know when Wall Street analysts revise their NBTX stock forecasts and price targets.

Forecast return on equity

Is NBTX forecast to generate an efficient return?
Insufficient data to display

Forecast return on assets

Is NBTX forecast to generate an efficient return on assets?
Company
N/A
Industry
-0.13%

NBTX revenue forecast

What is NBTX's revenue in the next 3 years based on estimates from 1 analyst?
Avg 1 year Forecast
$46.4M+525.79%
Avg 2 year Forecast
$29.0M+291.41%
Avg 3 year Forecast
$2.7M-64.22%
NBTX's revenue is forecast to... subscribe to Premium to read more.
Forecast High Revenue Growth Forecast

NBTX revenue growth forecast

How is NBTX forecast to perform vs Biotechnology companies and vs the US market?
Company
-16.69%
Industry
34.07%
Market
7.56%
NBTX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Industry Forecast
NBTX's revenues are forecast to... subscribe to Premium to read more.
Forecast Revenue Growth vs Market Forecast

NBTX vs Biotech Stocks

TickerPricePrice TargetUp/downsideConsensus
NBTX$5.44N/AN/A
ARQT$2.04$21.33+945.74%Buy
ATAI$1.14$17.50+1,435.09%Strong Buy
SCPH$5.42$19.00+250.55%Buy
BIVI$4.99$11.00+120.44%Strong Buy
View Top Biotech Stocks

Nanobiotix Sa Stock Forecast FAQ

What is NBTX's revenue growth forecast for 2023-2025?

(NASDAQ: NBTX) Nanobiotix Sa's forecast annual revenue growth rate of -16.69% is not forecast to beat the US Biotechnology industry's average forecast revenue growth rate of 34.07%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 7.56%.

Nanobiotix Sa's revenue in 2023 is $7,170,212.On average, 1 Wall Street analysts forecast NBTX's revenue for 2023 to be $1,632,928,206, with the lowest NBTX revenue forecast at $1,632,928,206, and the highest NBTX revenue forecast at $1,632,928,206. On average, 1 Wall Street analysts forecast NBTX's revenue for 2024 to be $1,021,328,774, with the lowest NBTX revenue forecast at $1,021,328,774, and the highest NBTX revenue forecast at $1,021,328,774.

In 2025, NBTX is forecast to generate $93,360,512 in revenue, with the lowest revenue forecast at $93,360,512 and the highest revenue forecast at $93,360,512.

If you're new to stock investing, here's how to buy Nanobiotix Sa stock.

What is NBTX's forecast return on assets (ROA) for 2023-2026?

(NASDAQ: NBTX) forecast ROA is N/A, which is lower than the forecast US Biotechnology industry average of -0.13%.

What is NBTX's forecast return on equity (ROE) for 2023-2026?

(NASDAQ: NBTX) forecast ROE is N/A, which is considered weak.
©2023 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.